Icon

ZEGERID (nda021636)- (20MG/PACKET;1.68GM/PACKET,40MG/PACKET;1.68GM/PACKET)

OMEPRAZOLE; SODIUM BICARBONATE SALIX
20MG/PACKET;1.68GM/PACKET,40MG/PACKET;1.68GM/PACKET
Yes Yes
2016-Jul-16 Expired
None None
None No
ZEGERID is a proton pump inhibitor (PPI). ZEGERID for oral suspension and ZEGERID capsules are indicated in adults for: • Treatment of active duodenal ulcer • Treatment of active benign gastric ulcer • Treatment of erosive esophagitis (EE) due to acid-mediated gastroesophageal reflux disease (GERD) • Maintenance of healing of EE. ZEGERID for oral suspension is indicated in adults for: • Reduction of risk of upper gastrointestinal (GI) bleeding in critically ill patients.
2 0 2
Total Other Developers None
Drugs with Suitability No
20MG/PACKET;1.68GM/PACKET ** ** - - 2
40MG/PACKET;1.68GM/PACKET ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ******* ******, *** *********** * *** ***** **, ******** *****, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ****** *** ****** ****** ******* *********** **** **. *-*** /* ***** *** - **** **, *******, ******* ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** *-*\*\*, **** ****, *******, *********** *************, *********** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.